Stock Events

Stock Events

Ernexa Therapeutics 

$0.2
350
+$0+0.5% Today

Statistics

Day High
0.21
Day Low
0.19
52W High
4.05
52W Low
0.18
Volume
189,000
Avg. Volume
1,701,188
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.61
-0.47
-0.32
-0.18
Expected EPS
N/A
Actual EPS
N/A

Financials

-31,888.24%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
68,000Revenue
-21.68MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ERNA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ARK Innovation
ARKK
Mkt Cap0
ARK Innovation ETF focuses on disruptive innovation, directly competing with BIGZ's investment in innovative growth companies.
Invesco QQQ Trust Series 1
QQQ
Mkt Cap0
Invesco QQQ Trust tracks the NASDAQ-100 Index, including technology and innovation leaders, competing for similar investor interest.
Vanguard Information Technology
VGT
Mkt Cap0
Vanguard Information Technology ETF invests in tech stocks, overlapping with BIGZ's focus on innovation and growth sectors.
iShares Expanded Tech-Software Sector
IGV
Mkt Cap0
iShares Expanded Tech-Software Sector ETF focuses on software industry, a key area of innovation, competing with BIGZ's tech-oriented investments.
First Trust Dow Jones Internet Index Fund
FDN
Mkt Cap0
First Trust Dow Jones Internet Index Fund invests in internet companies, directly competing with BIGZ's emphasis on innovative and growth companies.
ARK Next Generation Internet
ARKW
Mkt Cap0
ARK Next Generation Internet ETF focuses on internet and tech innovation, competing in the same space as BIGZ.
State Street SPDR FactSet Innovative Technology
XITK
Mkt Cap0
SPDR FactSet Innovative Technology ETF targets technology and innovation, similar to BIGZ's investment strategy.
ROBO Global Robotics and Automation Index
ROBO
Mkt Cap0
ROBO Global Robotics and Automation Index ETF invests in robotics and automation, areas of innovation that BIGZ might also explore.
First Trust Cloud Computing
SKYY
Mkt Cap0
First Trust Cloud Computing ETF focuses on cloud computing companies, competing with BIGZ's investment in innovative tech sectors.

About

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Show more...
CEO
Mr. Sanjeev Luther
Employees
6
Country
US
ISIN
US1140823089

Listings

F
DE
8W4.F
XNYS
US
BTX
XNAS
US
ERNA
XNAS
US
ERNAW

0 Comments

Share your thoughts

FAQ

What is Ernexa Therapeutics stock price today?▼
The current price of ERNA is $0.2 USD — it has increased by +0.5% in the past 24 hours. Watch Ernexa Therapeutics stock price performance more closely on the chart.
What is Ernexa Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ernexa Therapeutics stocks are traded under the ticker ERNA.
Is Ernexa Therapeutics stock price growing?▼
ERNA stock has risen by +9.52% compared to the previous week, the month change is a -27.37% fall, over the last year Ernexa Therapeutics has showed a +9.47% increase.
When is the next Ernexa Therapeutics earnings date?▼
Ernexa Therapeutics is going to release the next earnings report on May 20, 2026.
What were Ernexa Therapeutics earnings last quarter?▼
ERNA earnings for the last quarter are -0.18 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ernexa Therapeutics revenue for the last year?▼
Ernexa Therapeutics revenue for the last year amounts to 68,000 USD.
What is Ernexa Therapeutics net income for the last year?▼
ERNA net income for the last year is -21.68M USD.
How many employees does Ernexa Therapeutics have?▼
As of April 06, 2026, the company has 6 employees.
In which sector is Ernexa Therapeutics located?▼
Ernexa Therapeutics operates in the Health Care sector.
When did Ernexa Therapeutics complete a stock split?▼
The last stock split for Ernexa Therapeutics was on June 12, 2025 with a ratio of 1:15.
Where is Ernexa Therapeutics headquartered?▼
Ernexa Therapeutics is headquartered in Cambridge, US.